Unicycive Therapeutics, Inc.
UNCY
$5.12
$0.091.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 175.12% | 176.12% | 57.86% | 31.99% | -46.56% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 19.91% | 26.75% | 68.63% | 42.57% | 278.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 170.24% | -20.39% | 24.71% | 28.24% | 41.41% |
| Total Current Assets | 141.55% | 132.37% | 58.20% | 33.24% | -32.98% |
|
|
|||||
| Total Current Assets | 141.55% | 132.37% | 58.20% | 33.24% | -32.98% |
| Net Property, Plant & Equipment | 51.17% | 43.26% | -75.83% | -61.10% | -27.51% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 140.14% | 130.46% | 55.16% | 31.20% | -32.90% |
|
|
|||||
| Total Accounts Payable | 188.26% | -18.40% | -63.80% | 74.64% | -47.35% |
| Total Accrued Expenses | -1.48% | -26.33% | -57.24% | -7.69% | -30.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 50.61% | 9.12% | -79.26% | -51.11% | 13.61% |
| Total Finance Division Other Current Liabilities | 34.31% | 104.90% | -10.67% | 43.44% | 25.60% |
| Total Other Current Liabilities | 34.31% | 104.90% | -10.67% | 43.44% | 25.60% |
| Total Current Liabilities | 37.87% | 58.82% | -21.48% | 25.55% | 3.67% |
|
|
|||||
| Total Current Liabilities | 37.87% | 58.82% | -21.48% | 25.55% | 3.67% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 38.28% | 60.12% | -21.86% | 22.44% | 1.54% |
|
|
|||||
| Common Stock & APIC | 58.33% | 59.28% | 45.37% | 40.00% | 103.24% |
| Retained Earnings | -32.87% | -39.67% | -26.22% | -41.90% | -41.64% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 224.24% | 234.52% | 306.37% | 34.58% | 210.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 224.24% | 234.52% | 306.37% | 34.58% | 210.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 224.24% | 234.52% | 306.37% | 34.58% | -47.58% |
|
|
|||||